Diagonal Bio (Sweden) Market Value
DIABIO Stock | 0.03 0 3.05% |
Symbol | Diagonal |
Diagonal Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Diagonal Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Diagonal Bio.
05/28/2024 |
| 11/24/2024 |
If you would invest 0.00 in Diagonal Bio on May 28, 2024 and sell it all today you would earn a total of 0.00 from holding Diagonal Bio AB or generate 0.0% return on investment in Diagonal Bio over 180 days. Diagonal Bio is related to or competes with Oncopeptides, and Doxa AB. More
Diagonal Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Diagonal Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Diagonal Bio AB upside and downside potential and time the market with a certain degree of confidence.
Downside Deviation | 8.31 | |||
Information Ratio | 0.0767 | |||
Maximum Drawdown | 162.09 | |||
Value At Risk | (12.09) | |||
Potential Upside | 16.67 |
Diagonal Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Diagonal Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Diagonal Bio's standard deviation. In reality, there are many statistical measures that can use Diagonal Bio historical prices to predict the future Diagonal Bio's volatility.Risk Adjusted Performance | 0.0731 | |||
Jensen Alpha | 1.49 | |||
Total Risk Alpha | (1.62) | |||
Sortino Ratio | 0.1986 | |||
Treynor Ratio | 0.7687 |
Diagonal Bio AB Backtested Returns
Diagonal Bio is out of control given 3 months investment horizon. Diagonal Bio AB secures Sharpe Ratio (or Efficiency) of 0.0828, which denotes the company had a 0.0828% return per unit of standard deviation over the last 3 months. We were able to analyze thirty different technical indicators, which can help you to evaluate if expected returns of 1.78% are justified by taking the suggested risk. Use Diagonal Bio Semi Deviation of 7.42, mean deviation of 10.37, and Downside Deviation of 8.31 to evaluate company specific risk that cannot be diversified away. Diagonal Bio holds a performance score of 6 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 2.3, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Diagonal Bio will likely underperform. Use Diagonal Bio semi deviation, sortino ratio, semi variance, as well as the relationship between the standard deviation and value at risk , to analyze future returns on Diagonal Bio.
Auto-correlation | -0.18 |
Insignificant reverse predictability
Diagonal Bio AB has insignificant reverse predictability. Overlapping area represents the amount of predictability between Diagonal Bio time series from 28th of May 2024 to 26th of August 2024 and 26th of August 2024 to 24th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Diagonal Bio AB price movement. The serial correlation of -0.18 indicates that over 18.0% of current Diagonal Bio price fluctuation can be explain by its past prices.
Correlation Coefficient | -0.18 | |
Spearman Rank Test | -0.37 | |
Residual Average | 0.0 | |
Price Variance | 0.0 |
Diagonal Bio AB lagged returns against current returns
Autocorrelation, which is Diagonal Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Diagonal Bio's stock expected returns. We can calculate the autocorrelation of Diagonal Bio returns to help us make a trade decision. For example, suppose you find that Diagonal Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
Timeline |
Diagonal Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Diagonal Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Diagonal Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Diagonal Bio stock over time.
Current vs Lagged Prices |
Timeline |
Diagonal Bio Lagged Returns
When evaluating Diagonal Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Diagonal Bio stock have on its future price. Diagonal Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Diagonal Bio autocorrelation shows the relationship between Diagonal Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Diagonal Bio AB.
Regressed Prices |
Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Diagonal Stock
Diagonal Bio financial ratios help investors to determine whether Diagonal Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagonal with respect to the benefits of owning Diagonal Bio security.